SCI Pharmtech Inc (4119)

Taiwan

Currency in TWD

52.20

0.00(0.00%)

Delayed Data·04/02

Fair Value

Unlock Value

Day's Range

50.80

52.20

52 wk Range

46.85

88.60

4119 Income Statement

Featured here, the Income Statement (earnings report) for SCI Pharmtech Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

2,689.22

864.22

899.74

1,204.16

1,523.74

Total Revenues Growth

aa.aa

+14.16%

-67.86%

+4.11%

+33.83%

+26.54%

Cost Of Revenues

aa.aa

1,414.89

656.13

608.56

853.84

1,113.07

Gross Profit

aa.aa

1,274.33

208.09

291.18

350.32

410.67

Gross Profit Growth

aa.aa

+36.18%

-83.67%

+39.93%

+20.31%

+17.22%

Gross Profit Margin %

aa.aa

47.39%

24.08%

32.36%

29.09%

26.95%

Other Operating Expenses, Total

aa.aa

222.75

134.43

172.21

190.02

212.38

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-6.66%	-39.65%	+28.1%	+10.34%	+11.77%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	43.37	30.35	39.65	49.09	42.68
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	179.39	104.08	132.56	140.93	169.7
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

1,051.58

73.66

118.97

160.3

198.29

Operating Income Growth

aa.aa

+50.85%

-93%

+61.52%

+34.74%

+23.7%

EBIT Margin %

aa.aa

39.1%

8.52%

13.22%

13.31%

13.01%

Net Interest Expenses

aa.aa

12.61

5.42

-0.12

4.44

Net Interest Expenses Growth

aa.aa

+175.91%

-20.72%

-45.78%

-102.27%

+3,708.94%

Interest Expense, Total

aa.aa

-0.04

-1.07

-6.29

-5.54

Interest And Investment Income

aa.aa

12.65

10.04

6.49

6.17

9.98

Other Non Operating Expenses, Total

aa.aa

-26.49

-4.13

19.36

-4.85

9.06

EBT, Excl. Unusual Items

aa.aa

1,037.69

79.52

143.75

155.33

211.79

Gain (Loss) On Sale Of Assets

aa.aa

-1.33

-0.58

Other Unusual Items, Total

aa.aa

-566.77

-16.26

259.48

211.32

431.46

EBT, Incl. Unusual Items

aa.aa

455.22

65.51

387.82

364.19

646.86

EBT, Incl. Unusual Items Growth

aa.aa

-35.99%

-85.61%

+492.04%

-6.09%

+77.62%

EBT, Incl. Unusual Items Margin

aa.aa

16.93%

7.58%

43.1%

30.24%

42.45%

Income Tax Expense

aa.aa

95.09

9.81

79.04

69.47

112.18

Net Income to Company

aa.aa

360.12

55.7

308.78

294.72

534.68

Minority Interest

aa.aa

Net Income

aa.aa

360.12

55.7

308.78

294.72

534.68

Net Income Growth

aa.aa

-36.94%

-84.53%

+454.4%

-4.55%

+81.42%

Net Income Margin %

aa.aa

13.39%

6.44%

34.32%

24.48%

35.09%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

360.12

55.7

308.78

294.72

534.68

Basic EPS - Continuing Operations

aa.aa

3.36

0.52

2.88

2.7

4.47

Basic EPS - Continuing Operations Growth

aa.aa

-36.94%

-84.53%

+454.4%

-6.3%

+65.93%

Diluted EPS - Continuing Operations

aa.aa

3.33

0.52

2.87

2.69

4.46

Diluted EPS - Continuing Operations Growth

aa.aa

-36.8%

-84.53%

+456.63%

-6.27%

+65.8%

Basic Weighted Average Shares Outstanding

aa.aa

107.3

107.31

109.31

119.51

Diluted Weighted Average Shares Outstanding

aa.aa

108.04

107.51

107.59

109.61

119.95

Dividend Per Share

aa.aa

0.37

0.22

1.25

1.5

Dividend Per Share Growth

aa.aa

-91.38%

+462.56%

+20%

EBITDA

aa.aa

1,182.83

135.59

207.95

303.68

429.73

EBITDA Growth

aa.aa

+42.18%

-88.54%

+53.36%

+46.04%

+41.51%

EBITDA Margin %

aa.aa

43.98%

15.69%

23.11%

25.22%

28.2%

EBIT

aa.aa

1,051.58

73.66

118.97

160.3

198.29

* In Millions of TWD (except for per share items)

FAQ

What was SCI Pharmtech’s revenue at year end?

At the end of the last reported fiscal year, SCI Pharmtech (4119) recorded total revenue of 1,523.74.

How much revenue did SCI Pharmtech report in the most recent quarter?

In its most recent quarterly earnings report, SCI Pharmtech posted revenue of 256.44.

What was SCI Pharmtech’s net income for the year?

For the full year, SCI Pharmtech reported net income of 534.68.

How much net income did SCI Pharmtech post in the last quarter?

In the most recent quarter, SCI Pharmtech (4119) posted net income of 14.00.

What was SCI Pharmtech’s gross profit for the year?

Gross profit for the year was reported at 410.67.

How much gross profit did SCI Pharmtech generate last quarter?

SCI Pharmtech recorded gross profit of 68.37 in its latest quarterly report.

What was SCI Pharmtech’s annual operating income?

For the full year, SCI Pharmtech (4119) reported operating income of 198.29.

What was SCI Pharmtech’s operating income last quarter?

Quarterly operating income was 18.73.

What was SCI Pharmtech’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 80.72.

What was the quarter-over-quarter change in EBITDA for SCI Pharmtech?

EBITDA changed by -33.25% compared to the last quarter.

What is SCI Pharmtech’s most recent gross profit margin?

The latest reported gross profit margin for SCI Pharmtech (4119) is 26.66%.

What is SCI Pharmtech’s most recent net income margin?

Net income margin based on recent financials is 5.46%.

What is SCI Pharmtech’s most recent EBIT margin?

SCI Pharmtech reported an EBIT margin of 7.30% based on current figures.

How did SCI Pharmtech’s revenue change compared to the previous quarter?

Revenue changed by -30.97% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for SCI Pharmtech?

In the latest quarter 2026, gross profit changed by -34.19% from the previous quarter.

PSEi Composite

6,382.04

+9.09

+0.14%

Nikkei 225

53,335.00

-483.04

-0.90%

Shanghai

4,075.92

-26.29

-0.64%

US 500

6,751.80

-46.3

-0.68%

US Tech 100

24,273.20

-275.5

-1.12%

DAX

24,491.06

-111.98

-0.46%

Dollar Index

97.805

-0.045

-0.05%

Market Movers

Name	Last	Chg. %	Vol.
Apex Mining	13.5600	+0.74%	21.12M
DigiPlus Interactive	14.940	+6.87%	16.37M
Aboitiz Power	43.00	-3.04%	4.90M
International Container	660.500	+0.30%	1.03M
Globe Telecom	1,726.00	+2.86%	270.08K
Globe Telecom Pref	1,678.00	+5.07%	169.30K
PLDT	1,405.00	+1.15%	154.73K

Name	Last	Chg. %	Vol.
Golden Haven	865.00	+27.39%	1.48K
Crown Equities	0.080	+9.59%	330.00K
SOCResources	0.231	+9.48%	40.00K
Vista Land Lifescapes Prf	83.25	+8.75%	9.13K
Philippine Realty	0.108	+6.93%	2.48M
DigiPlus Interactive	14.940	+6.87%	16.37M
A Brown Company Prf s B	110.00	+5.77%	100.00

Name	Last	Chg. %	Vol.
Easycall Communications	2.760	-16.11%	1.00K
Medco	0.097	-14.16%	2.16M
Vulcan	0.3100	-8.82%	460.00K
Macay	5.890	-8.68%	10.20K
Oriental Petrol	0.0120	-7.69%	294.10M
Supercity Realty Dev	22.00	-7.56%	5.80K
LBC Express	7.520	-5.53%	500.00

Trending Stocks

Name	Last	Chg. %	Vol.
Globe Telecom	1,726.00	+2.86%	270.08K
DigiPlus Interactive	14.940	+6.87%	16.37M
Monde Nissin	6.10	+1.33%	7.92M
RL Commercial REIT	7.53	+0.40%	7.29M
Apex Mining	13.5600	+0.74%	21.12M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aa A	2.260	+49.02%	3.368
Aaaaaa	292.000	+33.47%	389.732
Aaaa	34.000	+30.80%	44.472
Aaaaaaaa Aaa	1.300	+29.49%	1.683
Aaaaaaaa Aaa	2.790	+27.78%	3.565
Aaaaaaaaaa	7.2400	+25.98%	9.1210
Aaaaaaaaaaaa A	14.940	+23.56%	18.460

Name	Last	Upside	Fair Value
Aaa Aa A	2.260	+49.02%	3.368
Aaaaaa	292.000	+33.47%	389.732
Aaaa	34.000	+30.80%	44.472
Aaaaaaaa Aaa	1.300	+29.49%	1.683
Aaaaaaaa Aaa	2.790	+27.78%	3.565
Aaaaaaaaaa	7.2400	+25.98%	9.1210
Aaaaaaaaaaaa A	14.940	+23.56%	18.460

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

SCI Pharmtech Inc (4119)

4119 Income Statement

FAQ

What was SCI Pharmtech’s revenue at year end?

How much revenue did SCI Pharmtech report in the most recent quarter?

What was SCI Pharmtech’s net income for the year?

How much net income did SCI Pharmtech post in the last quarter?

What was SCI Pharmtech’s gross profit for the year?

How much gross profit did SCI Pharmtech generate last quarter?

What was SCI Pharmtech’s annual operating income?

What was SCI Pharmtech’s operating income last quarter?

What was SCI Pharmtech’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for SCI Pharmtech?

What is SCI Pharmtech’s most recent gross profit margin?

What is SCI Pharmtech’s most recent net income margin?

What is SCI Pharmtech’s most recent EBIT margin?

How did SCI Pharmtech’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for SCI Pharmtech?

Trending Stocks